Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Celgene Corporation    CELG

CELGENE CORPORATION (CELG)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Celgene Corporation
Develops human pharmaceuticals and agrochemicals

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases.

Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies.

The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax.

Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Number of employees : 7 132 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Net Product - REVLIMID5,80165.2%6,97463.8% +20.21%
Net Product - POMALYST/IMNOVID983.3011%1,31112% +33.3%
Net Product - ABRAXANE967.5010.9%973.408.9% +0.61%
Net Product - VIDAZA590.706.6%608.005.6% +2.93%
Net Product - OTEZLA471.705.3%1,0179.3% +115.65%
Net Product - THALOMID185.402.1%152.101.4% -17.96%
Other94.901.1%44.600.4% -53%
Net Product - Azacitidine for Injection83.900.9%66.000.6% -21.33%
Net Product - ISTODAX69.100.8%79.300.7% +14.76%
Net Product - Other8.400.1%4.300% -48.81%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States5,60463%7,01064.2% +25.08%
Europe2,62429.5%3,04627.9% +16.08%
All Other1,02811.5%1,17310.7% +14.17%
Managers
NameAgeSinceTitle
Mark Alles582004Chief Executive Officer & Director
Scott Andrew Smith552008President & Chief Operating Officer
Robert Hugin621999Executive Chairman
Peter N. Kellogg, MBA612014Chief Financial Officer & Executive Vice President
Joseph S. Camardo, MD62-Senior Vice President-Global Medical Affairs
Rupert J. Vessey, PhD522015President-Research & Early Development
Gilla Kaplan, PhD701998Independent Director
Michael D. Casey712002Lead Independent Director
James J. Loughlin, CPA742007Independent Director
Ernest Mario, PhD792007Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 970,616,931 785,304,177 80.9% 183,300,000 18.9% 80.9%
Shareholders
NameEquities%
The Vanguard Group, Inc. 53,187,472 6.76%
BlackRock Fund Advisors 39,473,198 5.01%
SSgA Funds Management, Inc. 31,533,937 4.01%
Fidelity Management & Research Co. 16,884,255 2.14%
Jennison Associates LLC 14,962,407 1.90%
T. Rowe Price Associates, Inc. 11,220,508 1.43%
Northern Trust Investments, Inc. 10,702,640 1.36%
Edgewood Management LLC 10,556,896 1.34%
Wellington Management Co. LLP 10,186,455 1.29%
Henderson Global Investors Ltd. 9,410,233 1.20%
Holdings
NameEquities%Valuation
Juno Therapeutics Inc (JUNO) 11,109,1609.73%498,912,376 USD
Agios Pharmaceuticals Inc (AGIO) 5,242,70410.8%336,948,586 USD
Acceleron Pharma Inc (XLRN) 6,118,47913.9%238,620,681 USD
BEIGENE LTD COM 32,746,41610.4%232,429,804 USD
Crispr Therapeutics AG (CRSP) 3,722,5349.17%71,844,906 USD
Epizyme Inc (EPZM) 3,674,6405.31%61,366,488 USD
Mesoblast limited (MSB) 15,453,8913.28%15,818,757 USD
Zymeworks Inc (ZYME) 1,539,4836.08%12,931,657 USD
Oncomed Pharmaceuticals Inc (OMED) 2,970,5887.89%11,971,470 USD
Alliqua Biomedical Inc (ALQA) 804,61016.1%2,623,029 USD
Markets and indexes
- Nasdaq Stock Market
- Nasdaq Global Select Market
- Nasdaq 100 / SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  CELG:US
- Reuters Code :  CELG.O
- Datastream Code :  
Company contact information
Celgene Corporation
86 avenue Morris
NJ 07901 Summit, New Jersey
États-Unis (les)

Phone : +1 908 673 9000
Fax : +1
Internet : http://www.celgene.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
CELGENE CORPORATION-11.25%83 526
JOHNSON & JOHNSON21.23%377 698
NOVARTIS11.34%218 728
PFIZER9.48%213 036
ROCHE HOLDING LTD.6.19%208 877
MERCK AND COMPANY-7.68%151 559
AMGEN18.98%127 332
SANOFI-4.75%108 784
NOVO NORDISK A/S29.05%102 185
BRISTOL-MYERS SQUIBB COMPANY5.82%102 163
BAYER5.77%101 894
ELI LILLY AND COMPANY17.01%95 190
ABBOTT LABORATORIES42.31%95 106
GLAXOSMITHKLINE-18.34%84 764
ASTRAZENECA6.41%81 598
ALLERGAN PLC-21.78%55 807
SHIRE-24.58%44 705
TAKEDA PHARMACEUTICAL CO LTD27.82%42 944
CHUGAI PHARMACEUTICAL CO LTD76.75%29 496
JIANGSU HENGRUI MEDICINE CO LTD43.69%27 842
ASTELLAS PHARMA INC-11.69%26 073
Connections : Celgene Corporation
European Federation of Pharmaceutical Industries & Assns
Family Promise
Choose New Jersey
Desmond Tutu Hiv Foundation
Atlantic Health System, Inc.
Rutgers University Foundation
Darden School Foundation
University of Virginia Darden School of Business
Eyenovia, Inc.
PharmAkea, Inc.
Princeton University
Chilton Memorial Hospital
Sidecar Therapeutics, Inc.
Receptos, Inc.
Bill & Melinda Gates Foundation Trust
Biotechnology Innovation Organization
HealthCare Institute of New Jersey
Orbus Therapeutics, Inc.
Rosemont College
Gilda's Club New York City
Mali Health Organizing Project
Gladstone Foundation (CA)
American College of Physicians Foundation
Taxis Pharmaceuticals, Inc.
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem